Literature for peptidase C01.032: cathepsin L

(References are filtered for relevance to Review. To remove the filter click here. See explanation.)

2021
1. Jackson,C.B., Farzan,M., Chen,B. and Choe,H.
   Mechanisms of SARS-CoV-2 entry into cells
   Nat Rev Mol Cell Biol PubMed  Europe PubMed DOI  V
2020
2. Barnett,B.P., Wahlin,K., Krawczyk,M., Spencer,D., Welsbie,D., Afshari,N. and Chao,D.
   Potential of Ocular Transmission of SARS-CoV-2: A Review
   Vision (Basel)4, PubMed  Europe PubMed DOI  V
3. Dana,D. and Pathak,S.K.
   A review of small molecule inhibitors and functional probes of human cathepsin L
   Molecules25, PubMed  Europe PubMed DOI  V  I
4. Seth,S., Batra,J. and Srinivasan,S.
   COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
   Front Mol Biosci7, 215-215. PubMed  Europe PubMed DOI  V
2017
5. Li,Y.Y., Fang,J. and Ao,G.Z.
   Cathepsin B and L inhibitors: a patent review (2010 - present)
   Expert Opin Ther Pat27, 643-656. PubMed  Europe PubMed DOI  V  I
2004
6. Hook,V.Y.H.
   Prohormone thiol protease
   [ISSN:0-12-079610-4]2, 1408-1413.  V
7. Kirschke,H.
   Cathepsin L
   [ISSN:0-12-079610-4]2, 1097-1102.  V
1994
8. Kirschke,H. and Wiederanders,B.
   Cathepsin S and related lysosomal endopeptidases
   Methods Enzymol244, 500-511. PubMed  Europe PubMed DOI  V
1981
9. Barrett,A.J. and Kirschke,H.
   Cathepsin B, cathepsin H and cathepsin L
   Methods Enzymol80, 535-561. PubMed  Europe PubMed DOI  V